PET scan for Lyme neuroborreliosis diagnosis
Part of Brain & nervous system, Infections clinical trials.
This trial tests whether a special PET scan (64Cu-DOTATATE) can help diagnose Lyme neuroborreliosis (LNB), an infection of the nervous system caused by Lyme disease. The study aims to see if this scan can detect the infection earlier or more accurately than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have symptoms that make your doctor suspect Lyme neuroborreliosis.
- You must be able to read and understand study information and agree to take part.
- You cannot be pregnant or breastfeeding.
- You cannot have already finished antibiotic treatment for Lyme disease.
- You must weigh less than 140 kg (about 308 pounds) to fit in the scanner.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special PET scan that uses a radioactive tracer (18F-mFBG) to see how much it is taken up by the heart. The goal is to help tell Lewy body disease (Parkinson's or Lewy body dementia) apart from other brain disorders.
This trial uses a special PET scan with a new tracer called 68Ga-DOTA-BLP to spot cancer and its spread in the body. It aims to see if this scan can find tumors in lymph nodes or other areas without needing more painful biopsies.
This trial tests a new type of PET scan using a radioactive tracer called 61Cu-NODAGA-LM3 to detect neuroendocrine tumors (NETs). The goal is to see if it works as well as or better than the standard scan. If you have a NET and need a scan for staging or treatment planning, you might be able to join.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial is testing a new radioactive imaging agent that targets a protein called Nectin-4, which is often found on lung tumors. The scan will help doctors see if the tumor is visible and how it spreads, which may guide better treatment decisions for lung cancer patients.
Hear when a new Borrelia Burgdorferi Neuroborreliosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.